In vitro-induced human airway hyperresponsiveness to bradykinin

European Respiratory Journal

Volumn 12, Issue 6, 1998, Pages 1301-1306

  Molimard, M ^a,b,e   Naline, E ^b   Boichot, E ^c   Devillier, P ^d   Lagente, V ^c   Begaud B ^a   Advenier, C ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d REIMS UNIVERSITY HOSPITAL   (France)

^e HÔPITAL PELLEGRIN   (France)

Author keywords

Bradykinin; Endotoxin; Human isolated bronchus; Interleukin 1 ; Thromboxane synthase

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; BRADYKININ; FLOSULIDE; INDOMETACIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PROSTACYCLIN; PROSTANOID; THROMBOXANE; THROMBOXANE A2; THROMBOXANE B2; THROMBOXANE SYNTHASE; VAPIPROST;

ADULT; AGED; AIRWAY; ARTICLE; BRONCHOSPASM; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0032438391     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12061301     Document Type: Article

References (31)

1. Empey DW, Lailinen LA, Jacobs L, Gold WN, Nadel JA. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976; 113: 131-139.
2. O'Connor SA, Jones DP, Collins JV, Heath RB, Campbell MJ, Leighton MH. Changes in pulmonary function after naturally acquired respiratory infection in normal persons. Am Rev Respir Dis 1979; 120: 1087-1093.
3. Rylander R, Bake B, Fischer JJ, Helander IM. Pulmonary function and symptoms after inhalation of endotoxin. Am Rev Respir Dis 1989; 140: 981-986.
4. Michel O, Duchateau J, Sergysels R. Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol 1989; 66: 1059-1064.
5. Bradley SG. Cellular and molecular mechanism of action of bacterial endotoxin. Ann Rev Microbiol 1979; 33: 67-94.
6. Kips JC, Tavernier J, Pauwels RA. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis 1992; 145: 332-336.
7. Dinarello CA. Interleukin-1. Rev Infect Dis 1984; 6: 51-94.
8. Van Oosterhout AJM, Nijkamp FP. Role of cytokines in bronchial hyperresponsiveness. Pulmon Pharmacol 1993; 6: 225-236.
9. Tsukagoshi H, Sakamoto T, Xu W, Bames PJ, Chung KF. Effect of interleukin-1β on airway hyperresponsiveness and inflammation in sensitized and non-sensitized Brown-Norway rats. J Allergy Clin Immunol 1994; 93: 464-469.
10. Barnes PJ. Bradykinin and asthma. Thorax 1992; 47: 979-983.
11. Fuller RW, Dixon CMS, Cuss FMC, Barnes PJ. Bradykinin induced bronchoconstriction in humans. Am Rev Respir Dis 1987; 135: 176-180.
12. Molimard M, Martin CAE, Naline E, Hirsch A, Advenier C. Contractile effects of bradykinin on the isolated human small bronchus. Am J Respir Crit Can Med 1994; 149: 123-127.
13. 2 and thromboxane prostanoid receptors. Am J Respir Crit Care Med 1994; 150: 1012-1018.
14. 2 in bradykinin-induced human isolated small bronchi contraction. Eur J Pharmacol 1995; 278: 49-54.
15. Hakonarson H, Herrick DJ, Serrano PG, Grunstein MM. Mechanism of cytokine-induccd modulation of β-adrenoceptor responsiveness in airway smooth muscle. J Clin Invest 1996; 97: 2593-2600.
16. Klein T, Nüsing RM, Pfeilschifter J, Ullrich V. Selective inhibition of cyclooxygenase 2. Biochem Pharmacol 1994; 48: 1605-1610.
17. Félétou M, Martin CAE, Molimard M, et al. In vitro effects of Hoe140 in human bronchial and vascular tissue. Eur J Pharmacol 1995; 274: 57-64.
18. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassay of eicosanoids using acetylcholinesterase as label: an alternative to radioimmimoassay. Anal Chem 1985; 57: 1170-1174.
19. Hock FJ, Wirth K, Altus U, et al. Hoe 140,a new potent and long-actina bradykinin-antaeonist: in vitro studies. Br J Phamacol 1991; 102: 769-773.
20. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980; 32: 1-46.
21. Marceau F. Kinin B1 receptors: a review, Immunopharmacology 1995; 30: 1-26.
22. 9-BK to rabbit anterior mesenteric vein. Can J Physiol Pharmacol 1982; 60: 1551-1555.
23. Butt SK, Dawson LG, Hall JM. Bradykinin B, receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis. Br J Pharmacol 1995; 114: 612-617.
24. 9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin. Br J Pharmacol 1996; 117: 793-798.
25. Bathon JM, Manning D, Goldman DW, Towns MC, Proud D. Characterization of kinin receptor on human synovial cells and upresulation of receptor number by interleukin-1. J Pharmacol Exp Ther 1992; 260: 384-392.
26. 2 production. Br J Pharmacol 1994; 113: 389-394.
27. Tsukagoshi H, Sun J, Kwon O, Barries PJ, Chung KF. Role of neutral endopeptidase in bronchial hyperresponsiveness to bradykinin induced by IL-1β. J Appl Physiol 1995; 78: 921-927.
28. Tsukagoshi H, Haddad E-B, Barnes PJ, Chung KF. Bradykinin receptor subtypes in rat lung: effect of interleukin-1β. J Pharmacol Exp Ther 1995; 273: 1257-1263.
29. Cisar LA, Mochan E, Schimmel R. Interleukin-1 selectively potentiates bradykinin-stimulatcd arachidonic acid release from human sinovial fibroblasts. Cell Signall 1993; 5: 463-472.
30. Mitchell JA, Belvisi MG, Akarasereenont P, et al. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: resulation by dexamethasone. Br J Pharmacol 1994; 113: 1008-1014.
31. Vicaut E, Rasetti C, Baudry N. Effects of tumor necrosis factor and interleukin-1 on the constriction induced by ansiotensin II in rat aorta. J Appl Physiol 1996; 80: 1891-1897.